![GlaxoSmithKline will not begin any new clinical trials in Russia](https://cdn.newsserve.net/ONPglobe256.png)
GlaxoSmithKline will not begin any new clinical trials in Russia
Britain’s second-biggest drug maker, GlaxoSmithKline, won’t begin any new clinical trials in Russia because of the war against Ukraine. It made the announcement following similar moves by major US pharmaceutical giants Pfizer, Merck and Eli Lilly. The UK’s biggest company in the industry, AstraZeneca, is still conducting trials – but is considering ending them, according [...]
Full Article